Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330

Kraft, Lucas, Roe, S. Mark, Gill, Raj and Atack, John R. ORCID: https://orcid.org/0000-0002-3410-791X 2018. Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallographica. Section D: Structural Biology 74 (10) , p. 973. 10.1107/S2059798318010380

Preview

PDF - Accepted Post-Print Version Download (1MB) | Preview

Abstract

Lithium, which is still the gold standard in the treatment of bipolar disorder, has been proposed to inhibit inositol monophosphatase (IMPase) and is hypothesized to exert its therapeutic effects by attenuating phosphatidylinositol (PI) cell signalling. Drug-discovery efforts have focused on small-molecule lithium mimetics that would specifically inhibit IMPase without exhibiting the undesired side effects of lithium. L-690,330 is a potent bisphosphonate substrate-based inhibitor developed by Merck Sharp & Dohme. To aid future structure-based inhibitor design, determination of the exact binding mechanism of L-690,330 to IMPase was of interest. Here, the high-resolution X-ray structure of human IMPase in complex with L690,330 and manganese ions determined at 1.39 Å resolution is reported.

Item Type:	Article
Status:	Published
Schools:	Biosciences
Publisher:	International Union of Crystallography
ISSN:	2059-7983
Date of First Compliant Deposit:	21 November 2018
Date of Acceptance:	2 October 2018
Last Modified:	14 Nov 2024 16:30
URI:	https://orca.cardiff.ac.uk/id/eprint/116977

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item